{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T23:51:12Z","timestamp":1769212272773,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["81270598"],"award-info":[{"award-number":["81270598"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["81473486"],"award-info":[{"award-number":["81473486"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["81302044"],"award-info":[{"award-number":["81302044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014207","name":"National Public Health Grand Research Foundation","doi-asserted-by":"crossref","award":["201202017"],"award-info":[{"award-number":["201202017"]}],"id":[{"id":"10.13039\/501100014207","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundations of Shandong Province","award":["2009ZRB14176"],"award-info":[{"award-number":["2009ZRB14176"]}]},{"name":"Natural Science Foundations of Shandong Province","award":["ZR2012HZ003"],"award-info":[{"award-number":["ZR2012HZ003"]}]},{"name":"Technology Development Projects of Shandong Province","award":["2008GG2NS02018"],"award-info":[{"award-number":["2008GG2NS02018"]}]},{"name":"Technology Development Projects of Shandong Province","award":["2010GSF10250"],"award-info":[{"award-number":["2010GSF10250"]}]},{"name":"Technology Development Projects of Shandong Province","award":["2014GSF118021"],"award-info":[{"award-number":["2014GSF118021"]}]},{"name":"Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province","award":["BS2013YY003"],"award-info":[{"award-number":["BS2013YY003"]}]},{"name":"Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province","award":["BS2013YY009"],"award-info":[{"award-number":["BS2013YY009"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.bbrc.2015.06.145","type":"journal-article","created":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T21:22:02Z","timestamp":1435180922000},"page":"292-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["The STAT3 inhibitor WP1066 synergizes with vorinostat to induce apoptosis of mantle cell lymphoma cells"],"prefix":"10.1016","volume":"464","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7268-0047","authenticated-orcid":false,"given":"Kang","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-xiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-ling","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-li","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-pei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-yun","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2015.06.145_bib1","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics","volume":"7","author":"Jares","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2015.06.145_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.semcancer.2011.09.008","article-title":"New molecular targets in mantle cell lymphoma","volume":"21","author":"Parekh","year":"2011","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbrc.2015.06.145_bib3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2008.10.047","article-title":"HDAC expression and clinical prognosis in human malignancies","volume":"280","author":"Weichert","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2015.06.145_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-8722-3-5","article-title":"Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents","volume":"3","author":"Tan","year":"2010","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2015.06.145_bib5","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/bjh.12819","article-title":"A\u00a0multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma","volume":"165","author":"Ogura","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbrc.2015.06.145_bib6","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1200\/JCO.2010.32.1398","article-title":"Phase II study of vorinostat for treatment of relapsed or refractory indolent non-Hodgkin's lymphoma and mantle cell lymphoma","volume":"29","author":"Kirschbaum","year":"2011","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2015.06.145_bib7","doi-asserted-by":"crossref","first-page":"11291","DOI":"10.1158\/0008-5472.CAN-07-0593","article-title":"WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells","volume":"67","author":"Ferrajoli","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2015.06.145_bib8","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1158\/1078-0432.CCR-07-0524","article-title":"WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation","volume":"14","author":"Verstovsek","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2015.06.145_bib9","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1158\/1078-0432.CCR-08-0377","article-title":"A\u00a0novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells","volume":"14","author":"Kong","year":"2008","journal-title":"Clin. cancer Res."},{"key":"10.1016\/j.bbrc.2015.06.145_bib10","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1038\/sj.onc.1210031","article-title":"A\u00a0novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in\u00a0vitro and in\u00a0vivo","volume":"26","author":"Iwamaru","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2015.06.145_bib11","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/sj.bjc.6605691","article-title":"STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma","volume":"102","author":"Horiguchi","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2015.06.145_bib12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.canlet.2015.01.021","article-title":"The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6","volume":"359","author":"Lu","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2015.06.145_bib13","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1182\/blood-2012-04-424630","article-title":"Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells","volume":"120","author":"Zhang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2015.06.145_bib14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2015.06.145_bib15","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1111\/j.1349-7006.2009.01237.x","article-title":"Phase I and pharmacokinetic study of vorinostat (suberoylanilide hydroxamic acid) in Japanese patients with solid tumors","volume":"100","author":"Fujiwara","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2015.06.145_bib16","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1200\/JCO.2010.30.2307","article-title":"Phase I study of vorinostat in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study","volume":"28","author":"Ramalingam","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2015.06.145_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1200\/JCO.2005.01.9679","article-title":"Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies","volume":"24","author":"O'Connor","year":"2006","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2015.06.145_bib18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1349-7006.2009.01360.x","article-title":"Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma","volume":"101","author":"Watanabe","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2015.06.145_bib19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bbrc.2013.07.105","article-title":"JAB1 regulates unphosphorylated STAT3 DNA-binding activity through protein-protein interaction in human colon cancer cells","volume":"438","author":"Nishimoto","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2015.06.145_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/path.1253","article-title":"Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours","volume":"199","author":"Lai","year":"2003","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.bbrc.2015.06.145_bib21","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1158\/1535-7163.MCT-10-0238","article-title":"Degrasyn potentiates the antitumor effects of bortezomib in mantle cell lymphoma cells in\u00a0vitro and in\u00a0vivo: therapeutic implications","volume":"9","author":"Pham","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2015.06.145_bib22","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1158\/0008-5472.CAN-07-6091","article-title":"Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma","volume":"68","author":"Fantin","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2015.06.145_bib23","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/leu.2011.340","article-title":"Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy","volume":"26","author":"Gupta","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2015.06.145_bib24","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1158\/1078-0432.CCR-11-0955","article-title":"ABT-737 induces apoptosis in mantle cell lymphoma cells with a Bcl-2high\/Mcl-1low profile and synergizes with other antineoplastic agents","volume":"17","author":"Touzeau","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2015.06.145_bib25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1756-8722-6-90","article-title":"STAT inhibitors for cancer therapy","volume":"6","author":"Furqan","year":"2013","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2015.06.145_bib26","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.biocel.2007.03.001","article-title":"Histone deacetylase inhibitors: signalling towards p21cip1\/waf1","volume":"39","author":"Ocker","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15301996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15301996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T11:24:10Z","timestamp":1589541850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X15301996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0006291X15301996"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.06.145","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The STAT3 inhibitor WP1066 synergizes with vorinostat to induce apoptosis of mantle cell lymphoma cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.06.145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}